Continuing Education credits for the Symposium on Clinical Interventional Oncology (CIO) are provided by HMP Education.
The live activity will take place from September 23-25, 2022.
Additional credit applications and approvals are pending. This page will be updated upon approval.
Please contact firstname.lastname@example.org for any specific requests or more information.
The Symposium on Clinical Interventional Oncology (CIO) is designed for interventional radiologists, surgeons, oncologists, and other healthcare professionals involved in the treatment of cancer or looking to expand into this arena.
After attending the Symposium on Clinical Interventional Oncology (CIO), participants should be able to:
Describe catheter-based procedures to treat solid tumors, using the latest techniques and technologies
Assess the most appropriate therapeutic agent in catheter-directed therapy for hepatic malignancies
Demonstrate appropriate decision-making skills and techniques in ablation involving tumors of the kidney, bone, liver, and lung
Apply appropriate technique and biomarker testing of percutaneous biopsies
Determine the most appropriate imaging modalities during assessment, treatment, and follow-up of patients
Analyze the evidence behind the various modalities utilized in interventional oncology
In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This live activity has been approved for 17.5 AMA PRA Category 1 Credit™.
International Credit Recognition
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.
Bilateral reciprocal accreditation agreements exist between the Canadian Medical Association and the American Medical Association and the American Academy of Family Physicians.
The following Countries and Regions have reciprocity with the AMA/ACCME:
- Bavarian Chamber of Physicians (Germany)
- Bulgarian Union of Scientific Medical Societies (Bulgaria)
- Canadian Medical Association (Canada)
- Federation of Royal Colleges of Physicians (UK)
- French National Medical Council (France)
- Italian Federation of Scientific Medical Societies (Italy)
- National CME Commission of the Italian Ministry of Health (Italy)
- Royal College of Physicians and Surgeons of Canada (Canada)
- Spanish Accreditation Council for CME (Spain)
HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This live activity is designated for 17.5 AAPA Category 1 credits. PAs should only claim credit commensurate with the extent of their participation.
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
This continuing nursing education live activity awards 17.5 contact hours.
Provider approved by the California Board of Registered Nursing, Provider #13255.
Radiologic Techs (ARRT Credits)
CIO, taking place Friday, September 23 – Sunday, September 25, 2022 has been submitted for approval of ARRT Cat A+ Continuing Education credits by the Association of Vascular & Interventional Radiographers (AVIR).
AVIR is an ARRT Recognized Continuing Education Evaluating Mechanism (RCEEM).
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education may contact Samantha Conforti, Senior Manager, Accreditation and Compliance, by phone at 609.630.6208, by email at email@example.com, or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Conforti will review the grievance and respond within 30 days of receiving the complaint.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 770.751.7332/609.371.1137.
HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. HMP Education and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your non-public personal information.
Copyright © 2022 by HMP Education. All rights reserved.
The following companies have provided an educational grant in support of this activity: Genentech, a member of the Roche Group, Boston Scientific, Sirtex, Cook Medical, and Guerbet.